Plain-English translation of NCT06438315 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
SSCORE is a registry study that tracks heart attack patients to see how SuperSaturated Oxygen (SSO2) Therapy affects their recovery and overall heart health. Some patients in the study receive this new oxygen treatment during their initial heart attack care, while others receive standard treatment. Researchers will compare how both groups do over time to learn whether this therapy helps reduce damage to the heart.
Heart attacks cause significant damage to heart tissue and can lead to long-term heart failure. This study exists to understand whether this medication can reduce that damage and improve patient outcomes compared to standard care, and whether it might be cost-effective for hospitals and patients.
You likely qualify if…
You likely don't qualify if…
If you join this study, your doctors and the research team will track your health over time using your medical records from the hospital and your follow-up visits. You won't need to do anything special — the study simply follows your care as it normally happens. Some patients at participating hospitals may also be asked to have an optional heart imaging scan (cardiac MRI) to measure if the treatment reduced heart damage.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
United States